Portfolio Sync Solutions
Streamline your investment strategy with our portfolio synchronization tools. Seamlessly manage and track your holdings across platforms for enhanced
GET STARTEDImmunic Inc Analyst EPS Estimates
| Quarter | Number of Estimates | Low Estimate | High Estimate | Average Estimate |
|---|---|---|---|---|
| Q1 2026 | 7 | -$0.12 | -$0.06 | -$0.09 |
| Q2 2026 | 4 | -$0.09 | -$0.09 | -$0.09 |
| Q3 2026 | 3 | -$0.09 | -$0.09 | -$0.09 |
| Q4 2026 | 2 | -$0.09 | -$0.09 | -$0.09 |
| Q1 2027 | 2 | -$0.08 | -$0.08 | -$0.08 |
| Q2 2027 | 2 | -$0.08 | -$0.08 | -$0.08 |
| Q3 2027 | 2 | -$0.08 | -$0.08 | -$0.08 |
| Q4 2027 | 2 | -$0.09 | -$0.09 | -$0.09 |
| Q1 2028 | 3 | $0.08 | $0.08 | $0.08 |
| Q2 2028 | 6 | $0.15 | $0.15 | $0.15 |
| Q3 2028 | 5 | $0.15 | $0.15 | $0.15 |
| Q4 2028 | 4 | $0.15 | $0.15 | $0.15 |
Immunic Inc Earnings Date And Information
Immunic Inc last posted its earnings results on Thursday, November 13th, 2025. The company reported $-0.13 earnings per share for the quarter, topping analysts' consensus estimates of $-0.18 by $0.05. The company had revenue of 0 for the quarter and had revenue of 0 for the year. Immunic Inc has generated $-1 earnings per share over the last year ($-1 diluted earnings per share) and currently has a price-to-earnings ratio of -1.83. Immunic Inc has not formally confirmed its next earnings publication date, but the company's estimated earnings date is N/A based on prior year's report dates.
Immunic Inc Earnings History by Quarter
| Date | Quarter | Consensus Estimate | Reported EPS | Beat/Miss | Revenue Estimate | Actual Revenue |
|---|---|---|---|---|---|---|
| 11/13/2025 | Q3 2025 | -$0.18 | -$0.13 | 0.05 | $0 | $0 |
| 08/07/2025 | Q2 2025 | -$0.18 | -$0.20 | -0.02 | N/A | $0 |
| 05/15/2025 | Q1 2025 | -$0.25 | -$0.25 | 0 | N/A | $0 |
| 03/31/2025 | Q4 2024 | N/A | -$0.28 | N/A | N/A | $0 |
| 11/07/2024 | Q3 2024 | -$0.22 | -$0.24 | -0.02 | $6.00 K | $0 |
| 08/08/2024 | Q2 2024 | -$0.23 | -$0.21 | 0.02 | N/A | $0 |
| 05/08/2024 | Q1 2024 | -$0.27 | -$0.30 | -0.03 | N/A | $0 |
| 02/22/2024 | Q4 2023 | -$0.51 | -$0.48 | 0.03 | N/A | $0 |
| 09/29/2023 | Q3 2023 | N/A | -$0.51 | N/A | N/A | $0 |
| 08/03/2023 | Q2 2023 | -$0.52 | -$0.54 | -0.02 | N/A | $0 |
| 05/11/2023 | Q1 2023 | -$0.54 | -$0.53 | 0.01 | N/A | $0 |
| 02/23/2023 | Q4 2022 | -$0.82 | -$2.78 | -1.96 | N/A | $0 |
| 11/03/2022 | Q3 2022 | -$0.64 | -$0.73 | -0.09 | N/A | $0 |
| 08/04/2022 | Q2 2022 | -$0.68 | -$0.72 | -0.04 | N/A | $0 |
| 05/10/2022 | Q1 2022 | -$0.80 | -$0.72 | 0.08 | N/A | $0 |
| 02/24/2022 | Q4 2021 | -$0.73 | -$0.84 | -0.11 | N/A | $0 |
| 11/04/2021 | Q3 2021 | -$0.81 | -$0.76 | 0.05 | N/A | $0 |
| 08/06/2021 | Q2 2021 | -$0.72 | -$0.82 | -0.1 | N/A | $0 |
| 05/06/2021 | Q1 2021 | -$0.69 | -$1.63 | -0.94 | N/A | $0 |
| 02/26/2021 | Q4 2020 | -$0.59 | -$0.54 | 0.05 | N/A | $0 |
Explore Related Stocks for Market Trends
Explore our related stocks for the latest market trends and stock news to stay informed and make better decisions.
Immunic Inc Earnings: FAQ's
In the previous quarter, Immunic Inc (:IMUX) reported $-0.13 earnings per share (EPS) to beat the analysts' consensus estimate of $-0.18 by $0.05.
The conference call for Immunic Inc's latest earnings report can be listened to online.
The conference call transcript for Immunic Inc's latest earnings report can be read online.
Immunic Inc (:IMUX) has a recorded net income of $-100,507,000.Immunic Inc has generated $-1 earnings per share over the last four quarters.
Immunic Inc (:IMUX) has a price-to-earnings ratio of -1.83 and price/earnings-to-growth ratio is -0.16.